Latest Breaking News On - Chief executive chaim - Page 1 : comparemela.com

By Denny Jacob BrainStorm Cell Therapeutics shares rose 7.2% to 35 cents following a submitted special protocol assessment request to the Food and Drug.

Chaim lebovitsDenny jacobDrug administrationStorm cell therapeuticsChief executive chaimArticle normalFinancial performanceShare price movement disruptionsCorporate industrial newsPolitical general newsGene cell therapyMedical treatments proceduresEquity marketsCommodity financial market newsContent typesFactiva filters